StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$12.46−1.41 (-10.20%)

Close on Nov 18, 2026Market cap $1.62BP/E –Yield –

SkinHealth Systems revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

SkinHealth Systems's revenue for the twelve months ending Jun 30, 2026 was $290.05M, down 6.5% year over year. For fiscal 2025 it was $300.79M, down 10.0% from the year before. The highest annual figure on record is $397.99M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$300.79M-10.0%
FY2024Dec 31, 2024$334.29M-16.0%
FY2023Dec 31, 2023$397.99M+8.8%
FY2022Dec 31, 2022$365.88M+40.7%
FY2021Dec 31, 2021$260.09M+118.4%
FY2020Dec 31, 2020$119.09M-28.5%
FY2019Dec 31, 2019$166.62M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$72.11M-7.8%
Q1 FY2026Mar 31, 2026$64.91M-6.7%
Q4 FY2025Dec 31, 2025$82.37M-1.3%
Q3 FY2025Sep 30, 2025$70.66M-10.3%
Q2 FY2025Jun 30, 2025$78.19M-13.7%
Q1 FY2025Mar 31, 2025$69.58M-14.5%
Q4 FY2024Dec 31, 2024$83.50M-13.8%
Q3 FY2024Sep 30, 2024$78.80M-19.1%
Q2 FY2024Jun 30, 2024$90.59M-22.9%
Q1 FY2024Mar 31, 2024$81.40M-5.7%
Q4 FY2023Dec 31, 2023$96.82M-1.3%
Q3 FY2023Sep 30, 2023$97.41M+9.7%
Q2 FY2023Jun 30, 2023$117.48M+13.5%
Q1 FY2023Mar 31, 2023$86.28M+14.4%
Q4 FY2022Dec 31, 2022$98.13M+26.0%
Q3 FY2022Sep 30, 2022$88.79M+30.3%
Q2 FY2022Jun 30, 2022$103.54M+55.7%
Q1 FY2022Mar 31, 2022$75.42M+58.6%
Q4 FY2021Dec 31, 2021$77.89M+105.6%
Q3 FY2021Sep 30, 2021$68.15M+97.2%
Q2 FY2021Jun 30, 2021$66.51M+371.2%
Q1 FY2021Mar 31, 2021$47.54M–
Q4 FY2020Dec 31, 2020$37.88M–
Q3 FY2020Sep 30, 2020$34.56M–
Q2 FY2020Jun 30, 2020$14.12M–

More SkinHealth Systems figures

See a number that looks wrong?